Monday, September 20, 2010 1:30:16 PM
http://www.bcsc.bc.ca/uploadedFiles/NI43-101(1).pdf
For everything not specifically addressed by the NI compliance standards, I would otherwise assume the company's disclaimer below about covers it.
DISCLAIMER
LEGAL NOTE AND DISCLOSURES: All statements other than statements of historical fact included herein, including without limitation statements regarding the Company’s financial position, business strategy, and the plans and objectives of the Company’s management for future operations are forward-looking statements. When used in this release, such words such as “anticipate”, “expect”, “should”, “intend”, “projects”, “objective”, and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, business and economic conditions, ability to raise additional funds, competitive factors and pricing pressures, capacity and supply constraints and completion of current and anticipated contracts. Such statements reflect the views of the Company with respect to future events and are subject to these and other risks, uncertainties, and assumptions relating to the operations, results of operations, growth strategy and liquidity of the Company.
Readers are cautioned not to place undue reliance on these forward-looking statements. The Company does not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect future events or circumstances or to reflect the occurrence of unanticipated events. Opinions expressed herein are subject to change without notice. This report is published solely for information purposes and is not to be construed as an offer or the solicitation of an offer to buy any security in any State or Province. Past performance does not guarantee future performance.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM